YTHDF2 and hepatocellular carcinoma: Additionally, YTHDF2 is recognized as an oncogene that is upregulated in lung cancer and acute myeloid leukemia (AML) to promote tumor initiation and growth, exhibiting a completely opposite function as in HCC (60, 61).